• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Evaluation of anti-tubercular activity of linolenic acid and conjugatedlinoleic acid as effective inhibitors against Mycobacterium tuberculosis

    2016-11-29 12:06:03WonHyungChoi

    Won Hyung Choi

    Department of Biomedical Science, and Department of Medical Zoology, Kyung Hee University School of Medicine, 26 Kyunghee-daero, Dongdaemun-gu, Seoul 130-701, Republic of Korea

    Evaluation of anti-tubercular activity of linolenic acid and conjugatedlinoleic acid as effective inhibitors against Mycobacterium tuberculosis

    Won Hyung Choi*

    Department of Biomedical Science, and Department of Medical Zoology, Kyung Hee University School of Medicine, 26 Kyunghee-daero, Dongdaemun-gu, Seoul 130-701, Republic of Korea

    ARTICLE INFO

    Article history:

    Received 15 November 2015

    Received in revised form 20 December 2015

    Accepted 15 January 2016

    Available online 20 February 2016

    MGIT 960 system

    Tuberculosis

    Drug susceptibility testing

    γ-linolenic acid

    Objective: To evaluate a new pharmacological activity/effect of linolenic acid (α- and γ-form) and conjugated-linoleic acid (CLA) causing antibacterial activity against Mycobacterium tuberculosis (Mtb). Methods: The anti-Mtb activity/effect of linolenic acid and CLA were determined using different anti-Mtb indicator methods such as resazurin microtiter assay (REMA) and MGIT 960 system assay. The Mtb was incubated with various concentrations (12.5-200) μg/mL of the compounds and anti-Mtb first-line drugs for 5 d in the REMA, and for 3 wk in MGIT 960 system assay. Results: Linolenic acid and CLA obviously indicated their anti-Mtb activity/effect by strongly inhibiting the growth/proliferation of Mtb in a dosedependent manner in the REMA and the MGIT 960 system assay. Interestingly, linolenic acid and CLA consistently induced anti-Mtb activity/effect by effectively inhibiting the growth/ proliferation of Mtb in MGIT 960 system for 21 d with a single-treatment, and their minimum inhibitory concentrations were measured as 200 μg/mL respectively. Conclusions: These results demonstrate that linolenic acid and CLA not only have effective anti-Mtb activity/ properties, but also induce the selective-anti-Mtb effects by strongly inhibiting and blocking the growth/proliferation of Mtb through a new pharmacological activity/action. Therefore, this study provides novel perspectives for the effective use of them and the potential that can be used as potent anti-Mtb candidate drugs, as well as suggests the advantage of reducing the cost and/or time for developing a new/substantive drug by effectively repurposing the existing drugs or compounds as one of new strategies for the global challenge of tuberculosis.

    1. Introduction

    The rapid emergence of tuberculosis (TB) is still causing a serious global challenge and difficulty including drug-resistant TB despite various global efforts such as hygiene education, environment improvement, and drug development. Mycobacterium tuberculosis (Mtb) is a major infectious factor causing the highest human mortality through the co-infection with HIV/AIDS as one of the most dangerous infectious bacteria globally. In 2013, 9.0 millionpeople were estimated as new TB, 1.5 million died from the disease, and 360 000 of them were HIV-positive. In addition, 1.1 million of the 9 million people diagnosed as new TB cases in 2013 were HIV-positive. Recently, TB cases co-infected with HIV/AIDS indicated the highest infectious rate in the African region compared with the other countries, particularly, in southern Africa. Furthermore, most of the estimated TB cases in 2013 occurred in Asia (56%) and the African region (29%), and the three countries of the largest number of TB cases were India (2.0 million-2.3 million), China (0.9 million-1.1 million), and Nigeria (340 000-880 000)[1,2]. For these reasons, various studies for the treatment and/or the inhibition of TB that induces drug-resistance to existing agents have been carried out in the drug discovery field worldwide. Although various anti-TB drugs (from first-line drugs to third-line drugs) were developed for the treatment of TB-patients, they have showed the limit in reducing thecurrent TB patients. Recently, compounds such as PA 824, SQ 109, bedaquiline, and linezolid repurposed through chemical remodeling of the existing drugs as well as new compounds such as Q203, TMC 207, pyridomycin, and thiophenes are being tested in Phase I or Phase III trials as novel anti-TB drugs[1,3-7]. Until recently, in spite of the discovery of new targets and/or drugs for treating TB, the rapid emergence of TB, and multidrug-resistant TB (MDR-TB) or extensively drug-resistant TB has still caused serious concerns in the public health field worldwide. For these reasons, various studies for developing the effective anti-TB drugs with novel mechanisms of action, low cytotoxicity and safety are urgently needed to block and/or to inhibit the TB. In this aspect, this study was carried out to evaluate anti-Mtb activity/effect/ability of linolenic acid (α- and γ-form) and conjugated-linoleic acid (CLA) that effectively act as bioactive substance, and to identify the potential for developing them as novel anti-tubercular drugs.

    2. Materials and methods

    2.1. Materials

    Various materials used in this study, rifampicin, isoniazid, linolenic acid (α-and γ-form), CLA [conjugated(9Z,11E)-linoleic acid, conjugated(9E,11E)-linoleic acid, and conjugated(10E,12Z)-linoleic acid], resazurin powder and DMSO, were purchased from Sigma-Aldrich Chemical, Co., Ltd. (St, Louis, MO, USA), and MGITTM960 system indicator 7mL grwoth media tubes with BACTEC?MGIT? 960 supplement kit were purchased from Becton-Dickinson and Company (Sparks, MD, USA). All other chemicals and reagents were purchased from Merck Chemical Co., Ltd. (Darmstadt, Germany) and Sigma-Aldrich Chemical Co., Ltd. (St. Louis, MO, USA).

    2.2. Preparation of anti-Mtb drugs

    The anti-Mtb first-line drug, isoniazid, was dissolved in sterile distilled water, and rifampicin was dissolved in DMSO, to a concentration of 50 mg/mL according to the manufacturer’s instruction. The anti-Mtb first-line drugs were used as reference standard drugs. All compounds were filtered using 0.2 μm membrane syringe filter (Roshi Kaisha, Ltd., Tokyo, Japan) before use and stored at -80 ℃ deep-freezer until use.

    2.3. Preparation and growth conditions of Mtb

    Mtb H37RV(ATCC 27294) used in this study was purchased from American Type Culture Collection (Manassas, VA, USA). Mtb H37RVwas grown in Middlebrook 7H9 broth (Difco Laboratories, Detroit, MI, USA) supplemented with 10% (V/V) oleic acid/ albumin/dextrose/catalase enrichment (Becton-Dickinson and Company, Sparks, MD, USA) and 0.05%(v/v) Tween 80 (Sigma-Aldrich Chemical, St, Louis, MO, USA) to the log phase at 37 ℃ for 4-5 wk on shaking incubation of 100 rpm.

    2.4. Drug susceptibility testing of Mtb

    The in vitro anti-Mtb activity of linolenic acid (α- and γ-form) and CLA [conjugated(9Z,11E)-linoleic acid, conjugated(9E,11E)-linoleic acid, and conjugated(10E,12Z)-linoleic acid] against Mtb was confirmed by resazurin microtiter assay (REMA) using a 96-well micro-plate. Briefly, Mtb was grown in fresh Middlebrook 7H9 broth supplemented with 10% (v/v) oleic acid/albumin/dextrose/ catalase enrichment and 0.05% (v/v) Tween 80 until the culture reached a turbidity equal to that of 1.0 McFarland standard (3.0 × 108CFU/mL) at 37 ℃. The bacteria were adjusted to a density of 2 × 106CFU/mL in fresh culture broth. Finally, the bacterial suspensions were inoculated into all wells of a 96 well microtiter plate containing final concentrations (12.5-200) μg/mL of linolenic acid (α- and γ-form), CLA [conjugated(9Z,11E)-linoleic acid, conjugated(9E,11E)-linoleic acid, and conjugated(10E,12Z)-linoleic acid] and anti-TB first-line drugs (1.25-5) μg/mL, and Mtb growth controls containing no anti-Mtb first-line drugs and blank controls without inoculation were also included. The 96 well-plates, covered with lids, placed in a plastic bag, were incubated at 37 ℃ for 5 d. After incubation, 20 μL of freshly prepared 0.05% (w/v) resazurin solution was added to all wells of a 96 well microtiter plate, and the plates were re-incubated at 37 ℃ for 36 h. A change in color from blue to pink indicating bacterial growth was observed after 36 h of incubation. The minimum inhibitory concentration (MIC) was expressed as the lowest concentration of the drug that inhibited Mtb growth or prevented change in color of the resazurin from blue to pink based on a REMA.

    2.5. Evaluation of drug susceptibility of Mtb by MGIT 960 system assay

    To evaluate anti-Mtb effects of linolenic acid (α- and γ-form) and CLA [conjugated(9Z,11E)-linoleic acid, conjugated(9E,11E)-linoleic acid, and conjugated(10E,12Z)-linoleic acid] against the growth/ proliferation of Mtb, the drug susceptibility testing of the strain was performed using the BACTECTMMGIT 960 system (Becton Dickinson and Company, Sparks, MD. USA.). In brief, 100 μL of a suspension of Mtb culture, adjusted to 9.6 × 106CFU/mL, was inoculated in an MGIT growth media tube with BACTECTMMGIT 960 growth supplement (Becton Dickinson and Company), which were incubated with different concentrations (12.5-200) μg/mL of the tested compounds and anti-Mtb first-line drugs (10 μg/mL), and Mtb growth controls containing no anti-Mtb first-line drugs were also included. They were incubated into the BACTECTMMGIT 960 system device for 3 wk for determination of Mtb drug susceptibility.

    2.6. Statistical analysis

    All results were expressed as mean ± standard deviation of three independent experiments. Statistical analysis of the data was performed using the Student's t-test and one-way analysis of variance.

    3. Results

    3.1. Evaluation of anti-Mtb activity of the compounds against Mtb

    The anti-Mtb activity of linolenic acid (α- and γ-form) and CLA [conjugated(9Z,11E)-linoleic acid, conjugated(9E,11E)-linoleic acid, and conjugated(10E,12Z)-linoleic acid] were evaluated using the REMA. After the bacteria were incubated with various concentrations (12.5-200) μg/mL of the compounds and anti-Mtb first-line drugs (rifampicin and isoniazid) for 5 d, the growth/proliferation of Mtb were markedly inhibited in a concentration-dependent manner (Table 1), and the MIC values of linolenic acid (α- and γ-form) and CLA against the viability of Mtb were determined as 75 μg/ mL and 100 μg/mL, respectively (Table 2). Furthermore, all the compounds demonstrated their Mtb-inhibitory effects as well as anti-Mtb activity through the bacterial color change observed in the REMA. In the REMA, the superiority among the compounds regarding anti-Mtb activity/effect was confirmed that linolenic acid (α- and γ-form) was more effective compared with the CLA. These results demonstrate that the compounds not only induce anti-Mtb activity by strongly inhibiting the growth/proliferation of Mtb, but also have the potential that can be developed as potent anti-Mtb agents through their new pharmacological function/action.

    3.2. Anti-Mtb effects of the compounds against the growth/ proliferation of Mtb

    The anti-Mtb effects of the compounds against Mtb were further evaluated using the MGIT 960 system assay. The bacteria were incubated with various concentrations (12.5-200) μg/mL of the compounds and anti-Mtb first-line drugs (10 μg/mL) in an MGIT growth media tube of the BACTECTMMGIT 960 system device for drug susceptibility testing for 3 wk, and their growth units were markedly inhibited in a concentration-dependent manner. Particularly, when Mtb was incubated with 100 μg/mL of the CLA, their growth units were detected at about 8.3 d, whereas 100 μg/mL of linolenic acid (α- and γ-form) strongly inhibited the growth/ proliferation of Mtb compared with the CLA, and the growth unit of Mtb was detected at 9.3 and 10.3 d, respectively (Figure 1).Furthermore, when Mtb was incubated with all the tested compounds (200 μg/mL), their growth units were not detected at 21 d. In this MGIT 960 system assay, linolenic acid (α- and γ-form) and CLA effectively inhibited the growth/proliferation of Mtb for 3 wk with a single treatment, which showed clearly that these compounds induced similar inhibitory effects against the growth/proliferation of Mtb. These results demonstrate that the compounds induce anti-Mtb activity/effect causing the inactivation of Mtb by effectively blocking or consistently inhibiting the growth/proliferation of Mtb, as well as have unique anti-mycobacterial properties that induce anti-Mtb activity in a concentration-dependent manner.

    Table 1Anti-Mtb activity of linolenic acid (α- andγ-form) and CLA against Mtb growth/proliferation determined by the REMA assay.

    Table 2MICs of linolenic acid (α- and γ-form) and CLA against the growth/proliferation of Mtb determined by different anti-Mtb assays.

    Figure 1. Anti-Mtb activity/effect of linolenic acid (α-and γ-form) and CLA measured using the MGIT 960 system assay.

    4. Discussion

    The recent infectious pathogens have enhanced their infectivity and viability through genetic mutation or adaptability to environmental variation, which affects the treatment or prevention of the disease as well as the novel drug discovery and development. Recently serious infectious diseases such as MERS, SARS, Influenza and Ebola have been occurred in various countries worldwide, particularly, in Asia, Middle East and Africa. These diseases have typically caused more serious risk to young children whose immune function is low and the elderly who have other underlying diseases compared with normal adults. In these aspects, TB is a contagious/infectious disease to cause infection through droplets, which has caused comparatively high prevalence and mortality rates worldwide. In addition, TB is the most dangerous factor among various infectious diseases, which accounted for the second leading cause of death among infectious diseases of the world’s population in 2013 and 2014[1,2]. In particular, the increase of HIV-co infection and the rapid appearance of MDR-TB strains strongly suggest an urgent need to develop effective/safe drugs for consistently treating TB as well as induce serious concerns regarding drug-resistance in the public health fields. Recently, in spite of various efforts to discover new anti-Mtb drugs, the development for effective/safe anti-TB drugs has been still faced with a global difficulty, including the cost & time and the indifference of global pharmaceutical companies. Until recently, novel antibiotics derived from diverse biological resources and synthetic compounds have been developed to treat infectious diseases or to inhibit pathogenic microorganisms. However, the overuse of antibiotics and anti-bacterial drugs has rapidly increased the incidence of multi-drug resistant bacteria, so that many medical doctors compared with the past were confronted with more difficulty to treat patients with serious bacterial infections such as MDR-TB and extensively drug-resistant TB. In addition, the current anti-TB drugs have been causing serious side effects such as hepatotoxicity, ototoxictiy, and nephrotoxicity. For these reasons, as one of feasible solutions for overcoming limitations of the drug’s side effects, a number of researches regarding anti-Mtb drugs were reported from active substances derived from diverse medicinal plants and biological resources, and some of natural products have been studied or developed as potent candidate substances for treating TB[8-12]. However, despite various efforts for developing novel anti-TB drugs, effective/safe next generation anti-Mtb agents that can be used as a potential anti-TB drug, the extracts, natural products, semi-synthetic compounds and/or biomedicine, have not yet been reported or released in pharmaceutical market. Recently, innovative and creative alternatives for developing effective/safe drugs through substantive solutions between scientists and pharmaceuticals are being required globally.

    In this aspect, the new pharmacological activity/effect of existing drugs/compounds used for treating different diseases can provide the advantages of both the safety and efficacy compared with newly developed drugs, which may be used or utilized as one of effective strategies for developing novel drugs and as one of feasible alternatives for developing effective/safe next-generation drugs. Moreover, the compounds derived from the repurposing of existing drugs may increase the potential for developing new-next generation drugs as a useful resource for developing new substances in a medical field. For these reasons, this study was focused on major points for the discovery of new candidate substances as one of various strategies for developing anti-Mtb drugs, which were the minimization of side effects, the safety of drugs, and the finding of novel pharmacological activity/effect/function/action of existing drugs or known compounds. In these perspectives, CLA and linolenic acid (α- and γ-form) are being used as adjuvant for both medical use and healthcare as bioactive substances derived from various biological resources, including medicinal plants and marine resources. Recently, new pharmacological activity/effect/actions of CLA and linolenic acid (α- and γ-form) have been variously reported as follows: 1) Anti-adipogenic effect of α-linolenic acid through AMP-activated protein kinase[13], 2) γ-linolenic acid increases the therapeutic efficacy of irradiation in the treatment of gliomas[14], 3) The modulatory effects of CLA against both obesity and inflammatory bowel disease through peroxisome proliferatoractivated receptor gamma pathway[15], 4) α-linolenic acid protects the heart from myocardial fibrosis and cardiac injury in the rat[16], 5) Anti-allergic effect of α-linolenic acid in the gut of murine food allergy model[17], 6) The effect of omega-3 polyunsaturated fatty acid including α-linolenic acid in treating patients with nonalcoholic steatohepatitis[18].

    Taken together, these studies indicate substantial and significant evidence that linolenic acid (α- and γ-form) and CLA have not only various pharmacological activities/effects/actions in both ‘in vitro’ and ‘in vivo’ but also the potential that can be used as therapeutic agents. However, in spite of the pharmacological activities/effects/actions of them provided through these studies,their anti-TB activity/effects against Mtb have not yet been reported in both ‘in vitro’ and ‘in vivo’. In these aspects, this study has begun from hypothesis that linolenic acid (α- and γ-form) and CLA may effectively inhibit or interrupt and modulate the growth/proliferation of Mtb causing TB, which can improve the safety and increase or induce the minimization of the side effects that are caused by drug treatment. As mentioned above, the results of this study showed anti-tubercular activity/effect/ability of CLA and linolenic acid (α- and γ-form) by strongly inhibiting or blocking the growth/ proliferation of Mtb through their novel pharmacological activity/ properties. Particularly, anti-Mtb activity/effect of linolenic acid (α -and γ-form) were effectively demonstrated through the selective Mtb susceptibility-indicator assays such as the REMA and MGIT 960 system assay. All the tested compounds consistently indicated anti-Mtb activity/effect by strongly inhibiting or blocking the growth/proliferation of Mtb for 21 d with a single treatment (200 μg/mL) in MGIT 960 system assay. In addition, the differences in anti-Mtb activity/effect of them were obviously confirmed in the MGIT 960 system assay and the REMA assay; Linolenic acid (γ -form) more effectively inhibited the growth/proliferation of Mtb compared with those of linolenic acid (α-form) and CLA. The important aspect that can be considered at this point is that all the tested compounds are unsaturated fatty acid. This suggests that when the compounds are bound with Mtb in the growth stages of Mtb, chemical-binding effects between the compound and the bacteria can be increased owing to its chemical properties such as chemical affinity, absorbability, melting point, and liposolubility. Furthermore, it implies that the biochemical reactions and/or functions of the cell wall of Mtb may be blocked or inhibited by the binding of the compounds, and suggests that a cascading intracellular signalingpathway of replication as well as cell cycle-key proteins in cytoplasm may be deactivated by the compound at check points that accelerate the growth/proliferation of Mtb.

    In summary, linolenic acid (α- and γ-form) and CLA strongly inhibited the growth/proliferation of Mtb that can induce TB in those with weakened immune systems through their novel pharmacological activity/effect/function, and their anti-Mtb activity/effect and action were demonstrated through different anti-Mtb indicator assays such as the MGIT 960 system assay and the REMA. In particular, linolenic acid (γ-form) more effectively inhibited the growth/ proliferation of Mtb compared with other compounds used in this study. These results showed not only the potential for the effective use of linolenic acid (α- and γ-form) and CLA as one of feasible solutions for inhibiting or blocking TB that causes a serious threat in public health fields, but also a new pharmacological function/action concerning anti-Mtb activity/effect of them against Mtb. Therefore, this study provides significant results that linolenic acid (α- and γ-form) and CLA can be effectively used or utilized as potent candidate drugs for developing new anti-Mtb drugs of the effective/ safe next-generation in the near future. In addition, this study suggests that the compounds have the potential which may decrease the cost and/or time in clinical trials through their repurposing.

    Conflict of interest statement

    The author declares that there is conflict of interest.

    [1] World Health Organization. Global tuberculosis report 2013. Geneva: World Health Organization Press; 2013.

    [2] World Health Organization. Global tuberculosis report 2014. Geneva: World Health Organization Press; 2014.

    [3] Koul A, Arnoult E, Lounis N, Guillemont J, Andries K. The challenge of new drug discovery for tuberculosis. Nature 2011; 469(7331): 483-490.

    [4] Hartkoorn RC, Sala C, Neres J, Pojer F, Magnet S, Mukherjee R, et al. Towards a new tuberculosis drug: pyridomycin - nature's isoniazid. EMBO Mol Med 2012; 4(10): 1032-1042.

    [5] Lee M, Lee J, Carroll MW, Choi H, Min S, Song T, et al. Linezolid for treatment of chronic extensively drug-resistant tuberculosis. N Engl J Med 2012; 367(16): 1508-1518.

    [6] Pethe K, Bifani P, Jang J, Kang S, Park S, Ahn S, et al. Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. Nat Med 2013; 19(9): 1157-1160.

    [7] Wilson R, Kumar P, Parashar V, Vilchèze C, Veyron-Churlet R, Freundlich JS, et al. Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis. Nat Chem Biol 2013; 9(8): 499-506.

    [8] Copp BR, Pearce AN. Natural products growth inhibitors of Mycobacterium tuberculosis. Nat Prod Rep 2007; 24(2): 278-297.

    [9] Tandon R, Ponnan P, Aggarwal N, Pathak R, Baghel AS, Gupta G, et al. Characterization of 7-amino-4-methylcoumarin as an effective antitubercular agent: structure-activity relationships. J Antimicrob Chemother 2011; 66(11): 2543-2555.

    [10] Saikia D, Parveen S, Gupta VK, Luqman S. Anti-tuberculosis activity of Indian grass KHUS (Vetiveria zizanioides L. Nash). Complement Ther Med 2012; 20(6): 434-436.

    [11] Gemechu A, Giday M, Worku A, Ameni G. In vitro anti-mycobacterial activity of selected medicinal plants against Mycobacterium tuberculosis and Mycobacterium bovis strains. BMC Complement Altern Med 2013; 13: 291; DOI: 10.1186/1472-6882-13-291.

    [12] Leitao F, Leitao SG, de Almeida MZ, Cantos J, Coelho T, da Silva PE. Medicinal plants from open-air markets in the State of Rio de Janeiro, Brazil as a potential source of new antimycobacterial agents. J Ethnopharmacol 2013; 149(2): 513-521.

    [13] Zhou X, Wu W, Chen J, Wang X, Wang Y. AMP-activated protein kinase is required for the anti-adipogenic effects of alpha-linolenic acid. Nutr Metab (Lond) 2015; 12(1): 10; DOI: 10.1186/s12986-015-0006-5.

    [14] Antal O, Peter M, Hackler L Jr, Man I, Szebeni G, Ayaydin F, et al. Lipidomic analysis reveals a radiosensitizing role of gamma-linolenic acid in glioma cells. Biochim Biophys Acta 2015; 1851(9): 1271-1282.

    [15] Yuan G, Chen X, Li D. Modulation of peroxisome proliferator-activated receptor gamma (PPAR γ) by conjugated fatty acid in obesity and inflammatory bowel disease. J Agric Food Chem 2015; 63(7): 1883-1895.

    [16] Folino A, Sprio AE, Di Scipio F, Berta GN, Rastaldo R. Alpha-linolenic acid protects against cardiac injury and remodelling induced by betaadrenergic overstimulation. Food Funct 2015; 6(7): 2231-2239.

    [17] Kunisawa J, Arita M, Hayasaka T, Harada T, Iwamoto R, Nagasawa R, et al. Dietary ω3 fatty acid exerts anti-allergic effect through the conversion to 17, 18-epoxyeicosatetraenoic acid in the gut. Sci Rep 2015; 5: 9750; DOI: 10.1038/srep09750.

    [18] Nogueira MA, Oliveira CP, Ferreira Alves VA, Stefano JT, Rodrigues LS, Torrinhas RS, et al. Omega-3 polyunsaturated fatty acids in treating nonalcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial. Clin Nutr 2015; DOI: 10.1016/j.clnu.2015.05.001.

    ent heading

    10.1016/j.apjtm.2016.01.021

    *Corresponding author: Won Hyung Choi, Department of Biomedical Science, and Department of Medical Zoology, Kyung Hee University School of Medicine, 26 Kyunghee-daero, Dongdaemun-gu, Seoul 130-701, Republic of Korea.

    Tel: +82-10-2071-5679

    Fax: +82-70-8269-5679

    E-mail: whchoi@khu.ac.kr

    亚洲av国产av综合av卡| 午夜免费鲁丝| 一本综合久久免费| 黄网站色视频无遮挡免费观看| av在线老鸭窝| 国产三级黄色录像| 国产熟女午夜一区二区三区| 国产高清videossex| 亚洲av成人一区二区三| 久久久久久人人人人人| avwww免费| 天堂中文最新版在线下载| 一区二区av电影网| 啦啦啦中文免费视频观看日本| 亚洲五月色婷婷综合| 日韩视频在线欧美| 免费观看av网站的网址| av片东京热男人的天堂| 王馨瑶露胸无遮挡在线观看| 18禁观看日本| 日本精品一区二区三区蜜桃| 日韩大码丰满熟妇| 亚洲欧洲日产国产| 亚洲国产精品成人久久小说| 啦啦啦免费观看视频1| 亚洲九九香蕉| 操美女的视频在线观看| 午夜91福利影院| 成年av动漫网址| 成年人免费黄色播放视频| 久久精品亚洲av国产电影网| 大码成人一级视频| 久久久久国产一级毛片高清牌| 亚洲国产毛片av蜜桃av| 久久亚洲精品不卡| 国产伦理片在线播放av一区| 91精品三级在线观看| 视频区欧美日本亚洲| 久久免费观看电影| 精品熟女少妇八av免费久了| 午夜成年电影在线免费观看| 黄色毛片三级朝国网站| 91九色精品人成在线观看| 在线 av 中文字幕| 一级a爱视频在线免费观看| 久久久久久久大尺度免费视频| 成年动漫av网址| 啦啦啦 在线观看视频| 老司机影院毛片| 最近中文字幕2019免费版| 美女高潮到喷水免费观看| 国产免费av片在线观看野外av| 亚洲 欧美一区二区三区| 亚洲成人免费电影在线观看| 亚洲国产精品999| 又大又爽又粗| 久久午夜综合久久蜜桃| 亚洲精品成人av观看孕妇| 国产免费av片在线观看野外av| 色精品久久人妻99蜜桃| 久久久久精品国产欧美久久久 | 91成人精品电影| 一个人免费在线观看的高清视频 | 亚洲精品第二区| 人妻 亚洲 视频| 欧美精品人与动牲交sv欧美| 男女高潮啪啪啪动态图| 一级黄色大片毛片| 人妻一区二区av| 国产色视频综合| 两个人看的免费小视频| 亚洲精品国产区一区二| 亚洲久久久国产精品| 欧美精品一区二区免费开放| 国产99久久九九免费精品| 免费在线观看影片大全网站| 久久精品人人爽人人爽视色| 日韩一卡2卡3卡4卡2021年| 国产成人av激情在线播放| 搡老熟女国产l中国老女人| 欧美 亚洲 国产 日韩一| 亚洲国产欧美网| 九色亚洲精品在线播放| 激情视频va一区二区三区| 免费在线观看影片大全网站| 亚洲成人免费av在线播放| 国产不卡av网站在线观看| 91成年电影在线观看| 国产精品 国内视频| 美女主播在线视频| av又黄又爽大尺度在线免费看| 国产片内射在线| 国产免费视频播放在线视频| 亚洲自偷自拍图片 自拍| 黄色视频在线播放观看不卡| 不卡一级毛片| 丝瓜视频免费看黄片| 三上悠亚av全集在线观看| 性少妇av在线| 后天国语完整版免费观看| 国产成人系列免费观看| 无遮挡黄片免费观看| 蜜桃在线观看..| 91av网站免费观看| 制服诱惑二区| 操美女的视频在线观看| 久久久久久久久免费视频了| 欧美国产精品va在线观看不卡| 另类精品久久| 天天影视国产精品| 国产免费现黄频在线看| 18在线观看网站| 久久久久国产一级毛片高清牌| 男男h啪啪无遮挡| 久久久精品区二区三区| 久久精品熟女亚洲av麻豆精品| 国产欧美亚洲国产| 精品久久久久久电影网| 色老头精品视频在线观看| 两个人免费观看高清视频| 最新的欧美精品一区二区| 两个人看的免费小视频| www.自偷自拍.com| 亚洲欧美一区二区三区黑人| 男女高潮啪啪啪动态图| 在线亚洲精品国产二区图片欧美| 国内毛片毛片毛片毛片毛片| 美女扒开内裤让男人捅视频| 日韩一区二区三区影片| 欧美激情极品国产一区二区三区| 日本vs欧美在线观看视频| 国产亚洲精品一区二区www | 亚洲一区中文字幕在线| 1024香蕉在线观看| av福利片在线| 夜夜骑夜夜射夜夜干| 男女无遮挡免费网站观看| 亚洲人成电影观看| 国产成人a∨麻豆精品| 一个人免费看片子| 亚洲一区二区三区欧美精品| 一区二区三区四区激情视频| 欧美av亚洲av综合av国产av| 免费看十八禁软件| 中文字幕高清在线视频| 欧美在线黄色| 搡老岳熟女国产| 又黄又粗又硬又大视频| av不卡在线播放| 婷婷成人精品国产| 曰老女人黄片| 亚洲三区欧美一区| 老司机靠b影院| 国产不卡av网站在线观看| 最近最新免费中文字幕在线| 国产熟女午夜一区二区三区| 欧美中文综合在线视频| 欧美乱码精品一区二区三区| 妹子高潮喷水视频| 搡老岳熟女国产| 欧美日本中文国产一区发布| 久久精品国产亚洲av高清一级| 精品国产乱码久久久久久小说| 国产成人啪精品午夜网站| 欧美久久黑人一区二区| 热re99久久国产66热| 两性午夜刺激爽爽歪歪视频在线观看 | 欧美人与性动交α欧美软件| 色婷婷久久久亚洲欧美| 秋霞在线观看毛片| 欧美+亚洲+日韩+国产| 欧美精品高潮呻吟av久久| 18禁国产床啪视频网站| 成人免费观看视频高清| cao死你这个sao货| 超色免费av| 操美女的视频在线观看| svipshipincom国产片| 亚洲色图综合在线观看| 九色亚洲精品在线播放| 999久久久国产精品视频| 欧美变态另类bdsm刘玥| 51午夜福利影视在线观看| 一进一出抽搐动态| 欧美午夜高清在线| 国产精品.久久久| 香蕉国产在线看| 伦理电影免费视频| 国产精品99久久99久久久不卡| 日韩欧美一区二区三区在线观看 | 一本久久精品| 国产在线观看jvid| 欧美在线一区亚洲| 欧美日韩亚洲国产一区二区在线观看 | 好男人电影高清在线观看| www.av在线官网国产| 丝袜人妻中文字幕| 老司机福利观看| 老司机亚洲免费影院| 伊人久久大香线蕉亚洲五| av有码第一页| 国产成人av教育| 亚洲av片天天在线观看| 亚洲专区中文字幕在线| 日本黄色日本黄色录像| 在线观看免费日韩欧美大片| 国产精品一区二区在线不卡| 久久人人爽人人片av| 欧美午夜高清在线| 美女主播在线视频| 亚洲成人手机| 欧美成人午夜精品| 亚洲成av片中文字幕在线观看| 成人手机av| 亚洲精品乱久久久久久| 夜夜骑夜夜射夜夜干| 久热这里只有精品99| 人成视频在线观看免费观看| 久久影院123| 精品国产超薄肉色丝袜足j| 亚洲成人国产一区在线观看| 免费观看a级毛片全部| 成人影院久久| 热99国产精品久久久久久7| 免费黄频网站在线观看国产| 天天添夜夜摸| 69av精品久久久久久 | 国产一区二区 视频在线| 亚洲三区欧美一区| 国产xxxxx性猛交| 亚洲一码二码三码区别大吗| 777米奇影视久久| 视频在线观看一区二区三区| 天天操日日干夜夜撸| e午夜精品久久久久久久| 丰满迷人的少妇在线观看| 一级毛片精品| 精品福利观看| 无遮挡黄片免费观看| 国产一区二区三区综合在线观看| 最近最新中文字幕大全免费视频| 美女主播在线视频| 高清在线国产一区| 国产在视频线精品| 亚洲伊人色综图| 亚洲精品美女久久久久99蜜臀| 欧美精品人与动牲交sv欧美| 日本vs欧美在线观看视频| 黄色怎么调成土黄色| 欧美日韩av久久| 精品亚洲成a人片在线观看| 免费在线观看完整版高清| 69av精品久久久久久 | 香蕉丝袜av| 免费观看a级毛片全部| 一级毛片电影观看| 美国免费a级毛片| 国产精品久久久久久精品古装| 欧美精品高潮呻吟av久久| 岛国毛片在线播放| 亚洲激情五月婷婷啪啪| 亚洲av男天堂| 久久青草综合色| 精品福利观看| av在线老鸭窝| 性高湖久久久久久久久免费观看| 这个男人来自地球电影免费观看| av又黄又爽大尺度在线免费看| 精品卡一卡二卡四卡免费| 天堂俺去俺来也www色官网| 无遮挡黄片免费观看| 美女高潮到喷水免费观看| 亚洲五月婷婷丁香| av网站在线播放免费| 精品少妇内射三级| 超碰97精品在线观看| 国产免费av片在线观看野外av| 69av精品久久久久久 | 免费观看a级毛片全部| 一级毛片女人18水好多| 美女视频免费永久观看网站| h视频一区二区三区| 亚洲欧美成人综合另类久久久| 91大片在线观看| 女人爽到高潮嗷嗷叫在线视频| 老司机靠b影院| 亚洲成人国产一区在线观看| 美女大奶头黄色视频| 久久久久视频综合| 9191精品国产免费久久| 久久久久久久大尺度免费视频| 亚洲精品一二三| 交换朋友夫妻互换小说| 各种免费的搞黄视频| 亚洲中文日韩欧美视频| 国产精品国产三级国产专区5o| 日韩电影二区| 精品久久久久久久毛片微露脸 | 日本猛色少妇xxxxx猛交久久| 欧美乱码精品一区二区三区| 另类精品久久| 1024香蕉在线观看| 日韩人妻精品一区2区三区| 亚洲第一欧美日韩一区二区三区 | 后天国语完整版免费观看| 青春草亚洲视频在线观看| 热re99久久精品国产66热6| 午夜免费观看性视频| 国产福利在线免费观看视频| 少妇人妻久久综合中文| 国精品久久久久久国模美| 妹子高潮喷水视频| 久久亚洲国产成人精品v| 欧美精品一区二区免费开放| 国产日韩一区二区三区精品不卡| 狠狠精品人妻久久久久久综合| 日韩熟女老妇一区二区性免费视频| 少妇人妻久久综合中文| 亚洲精品一卡2卡三卡4卡5卡 | 精品国产乱码久久久久久男人| 精品国产一区二区久久| 亚洲av成人一区二区三| 亚洲国产成人一精品久久久| 国产在线免费精品| 日本一区二区免费在线视频| 国产成人av激情在线播放| 国产精品国产三级国产专区5o| 另类亚洲欧美激情| 免费看十八禁软件| 国产亚洲午夜精品一区二区久久| 9热在线视频观看99| 亚洲第一青青草原| 丝袜人妻中文字幕| av天堂久久9| 午夜两性在线视频| 一本一本久久a久久精品综合妖精| 久久精品成人免费网站| www.熟女人妻精品国产| 9热在线视频观看99| 日韩欧美一区视频在线观看| 一级,二级,三级黄色视频| av天堂久久9| 999久久久精品免费观看国产| 亚洲精品美女久久av网站| bbb黄色大片| 99久久99久久久精品蜜桃| 国产亚洲精品第一综合不卡| 免费观看人在逋| 国产亚洲欧美精品永久| 午夜两性在线视频| 日韩,欧美,国产一区二区三区| 日韩有码中文字幕| 91九色精品人成在线观看| 国产精品久久久av美女十八| 男女免费视频国产| 国产一区二区 视频在线| 成人av一区二区三区在线看 | av天堂久久9| 亚洲精品中文字幕在线视频| 日韩三级视频一区二区三区| 视频区图区小说| 王馨瑶露胸无遮挡在线观看| 男女无遮挡免费网站观看| 日韩人妻精品一区2区三区| 亚洲欧洲精品一区二区精品久久久| 天堂俺去俺来也www色官网| 国产欧美日韩精品亚洲av| 久久精品久久久久久噜噜老黄| 精品高清国产在线一区| av天堂在线播放| 日本a在线网址| 亚洲国产中文字幕在线视频| 婷婷成人精品国产| 国产精品.久久久| 国产成人免费观看mmmm| 免费在线观看视频国产中文字幕亚洲 | 深夜精品福利| 三级毛片av免费| a级毛片黄视频| 久久久久国产一级毛片高清牌| 女人爽到高潮嗷嗷叫在线视频| kizo精华| 成人国语在线视频| 欧美 日韩 精品 国产| 久久精品国产亚洲av高清一级| 欧美少妇被猛烈插入视频| 国产精品一二三区在线看| 美女脱内裤让男人舔精品视频| 我的亚洲天堂| 久久久欧美国产精品| 精品久久久久久电影网| 不卡一级毛片| 欧美日韩中文字幕国产精品一区二区三区 | 久久人人爽av亚洲精品天堂| 欧美在线黄色| 久久这里只有精品19| 秋霞在线观看毛片| 成年美女黄网站色视频大全免费| 嫁个100分男人电影在线观看| 50天的宝宝边吃奶边哭怎么回事| 午夜影院在线不卡| 日韩人妻精品一区2区三区| 少妇猛男粗大的猛烈进出视频| 在线观看免费视频网站a站| 国产一区二区在线观看av| 悠悠久久av| 日本a在线网址| 精品少妇内射三级| 美女中出高潮动态图| 三级毛片av免费| 狂野欧美激情性bbbbbb| 国产在线免费精品| 亚洲欧洲精品一区二区精品久久久| 在线亚洲精品国产二区图片欧美| 国产黄色免费在线视频| 久久 成人 亚洲| 国产av一区二区精品久久| 99久久国产精品久久久| 成年人午夜在线观看视频| 久久女婷五月综合色啪小说| 伦理电影免费视频| 乱人伦中国视频| tocl精华| www日本在线高清视频| 五月开心婷婷网| 丰满人妻熟妇乱又伦精品不卡| 丝袜喷水一区| 亚洲美女黄色视频免费看| 一本久久精品| 人人妻人人爽人人添夜夜欢视频| av网站在线播放免费| 999久久久国产精品视频| 中亚洲国语对白在线视频| 一本综合久久免费| 欧美在线黄色| 中文字幕人妻熟女乱码| 美女国产高潮福利片在线看| 老汉色av国产亚洲站长工具| 狂野欧美激情性xxxx| 不卡一级毛片| 免费看十八禁软件| 两性午夜刺激爽爽歪歪视频在线观看 | 久久久久网色| 亚洲性夜色夜夜综合| 美女福利国产在线| 欧美日韩中文字幕国产精品一区二区三区 | 国产欧美亚洲国产| 欧美精品av麻豆av| 久久久精品免费免费高清| 国产精品 欧美亚洲| 男女无遮挡免费网站观看| 色综合欧美亚洲国产小说| 午夜影院在线不卡| 在线av久久热| videos熟女内射| 国产精品亚洲av一区麻豆| 欧美av亚洲av综合av国产av| 波多野结衣一区麻豆| 国产视频一区二区在线看| 国产成人影院久久av| 亚洲三区欧美一区| 最新的欧美精品一区二区| 秋霞在线观看毛片| a在线观看视频网站| 亚洲熟女毛片儿| 亚洲一区二区三区欧美精品| 岛国在线观看网站| 大陆偷拍与自拍| 9191精品国产免费久久| 熟女少妇亚洲综合色aaa.| 免费在线观看影片大全网站| 女人久久www免费人成看片| 爱豆传媒免费全集在线观看| 精品亚洲乱码少妇综合久久| 久久久精品国产亚洲av高清涩受| 国产欧美日韩一区二区三区在线| 欧美日韩福利视频一区二区| 亚洲成人免费电影在线观看| 亚洲激情五月婷婷啪啪| 国产日韩欧美视频二区| 国产精品偷伦视频观看了| 欧美亚洲日本最大视频资源| 亚洲人成电影观看| 又黄又粗又硬又大视频| 高清黄色对白视频在线免费看| 在线十欧美十亚洲十日本专区| 久久人妻熟女aⅴ| 不卡av一区二区三区| 亚洲国产精品一区二区三区在线| 亚洲专区字幕在线| 精品国产乱码久久久久久男人| 日韩免费高清中文字幕av| 亚洲性夜色夜夜综合| 午夜福利影视在线免费观看| 成年美女黄网站色视频大全免费| 久久精品亚洲熟妇少妇任你| 天堂中文最新版在线下载| 精品久久久精品久久久| 欧美日韩中文字幕国产精品一区二区三区 | 成年av动漫网址| 国产成人一区二区三区免费视频网站| 精品国产超薄肉色丝袜足j| 男女边摸边吃奶| 亚洲精品一卡2卡三卡4卡5卡 | 国产精品欧美亚洲77777| 亚洲少妇的诱惑av| 日本撒尿小便嘘嘘汇集6| 97在线人人人人妻| 18禁裸乳无遮挡动漫免费视频| 在线观看一区二区三区激情| 国产区一区二久久| 一个人免费看片子| 亚洲精品乱久久久久久| 国产野战对白在线观看| 首页视频小说图片口味搜索| 97在线人人人人妻| e午夜精品久久久久久久| 黑人巨大精品欧美一区二区蜜桃| 国产成人av教育| 亚洲精品一区蜜桃| 色婷婷av一区二区三区视频| 十八禁高潮呻吟视频| 桃花免费在线播放| 欧美av亚洲av综合av国产av| 亚洲成国产人片在线观看| 国产精品久久久av美女十八| 老司机福利观看| 午夜免费观看性视频| av一本久久久久| 久久中文看片网| 欧美久久黑人一区二区| 91精品三级在线观看| av在线播放精品| 成人亚洲精品一区在线观看| 午夜91福利影院| 黄频高清免费视频| av不卡在线播放| av超薄肉色丝袜交足视频| 亚洲专区国产一区二区| 别揉我奶头~嗯~啊~动态视频 | 久久综合国产亚洲精品| 免费女性裸体啪啪无遮挡网站| 妹子高潮喷水视频| 国产男人的电影天堂91| 一二三四社区在线视频社区8| 在线 av 中文字幕| 制服诱惑二区| 精品一区二区三卡| 啦啦啦视频在线资源免费观看| 永久免费av网站大全| 999久久久国产精品视频| 亚洲欧洲日产国产| 日韩熟女老妇一区二区性免费视频| 欧美日韩精品网址| 日韩制服骚丝袜av| 黄片小视频在线播放| 高清欧美精品videossex| 后天国语完整版免费观看| 国产真人三级小视频在线观看| 国产av国产精品国产| 大型av网站在线播放| 狠狠精品人妻久久久久久综合| 国产精品欧美亚洲77777| 午夜福利在线免费观看网站| 一级黄色大片毛片| 成人国产av品久久久| 丝袜美腿诱惑在线| 国产亚洲一区二区精品| 91麻豆av在线| 日本黄色日本黄色录像| 欧美精品亚洲一区二区| 菩萨蛮人人尽说江南好唐韦庄| 亚洲国产精品999| 久久精品亚洲熟妇少妇任你| 亚洲人成电影免费在线| 亚洲精品久久成人aⅴ小说| 大片免费播放器 马上看| 欧美日韩成人在线一区二区| 国产精品久久久av美女十八| 日日爽夜夜爽网站| 亚洲av国产av综合av卡| 亚洲国产毛片av蜜桃av| 中文字幕av电影在线播放| 午夜福利在线观看吧| 亚洲伊人色综图| 久久久久久久久免费视频了| 永久免费av网站大全| 国产深夜福利视频在线观看| 亚洲av电影在线观看一区二区三区| 天堂中文最新版在线下载| 亚洲国产成人一精品久久久| 久久久久精品国产欧美久久久 | 脱女人内裤的视频| 人成视频在线观看免费观看| 人人妻,人人澡人人爽秒播| 制服人妻中文乱码| 满18在线观看网站| www.自偷自拍.com| 亚洲情色 制服丝袜| 纵有疾风起免费观看全集完整版| 99久久人妻综合| 黄色a级毛片大全视频| 日本a在线网址| 亚洲国产成人一精品久久久| 国产人伦9x9x在线观看| 国内毛片毛片毛片毛片毛片| 欧美日韩亚洲高清精品| 正在播放国产对白刺激| 亚洲七黄色美女视频| 久久久久久久国产电影| 91大片在线观看| 亚洲一码二码三码区别大吗| av天堂在线播放| 一级毛片女人18水好多| 视频在线观看一区二区三区|